Raymond James analyst Olivia Tong raised the firm’s price target on Procter & Gamble to $175 from $170 and keeps an Outperform rating on the shares. March quarter results demonstrated PG‘s continued focus on innovation and investment, which allowed for sales and margin upside despite arguably a more volatile macro backdrop, the firm says in a research note on Friday. As Procter & Gamble begins to lap more significant price increases in Q4, Raymond James expects the spread between price and volume to narrow while margin momentum should continue into 2024.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PG:
- P&G issues retrieval of limited number of Zevo insect killer value packs
- Procter & Gamble sees runway on productivity growth over next few years
- Procter & Gamble says organic sales grew across all categories in Q3
- Procter & Gamble Delivers Better-than-Expected Q3 Results
- Procter & Gamble reports Q3 operating margin up 40 bps y/y
